The best radiotherapy for the treatment of prostate cancer involves hypofractionation

Medical Physics

Volumn 33, Issue 9, 2006, Pages 3081-3084

  Fowler, John F ^a   Nahum, Alan E ^b   Orton, Colin G ^c  

^a Medical Radiation Research Centre   (United Kingdom)

^b CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYPOFRACTIONATION; PROSTATE CANCERS;

DISEASES;

ACADEMIC ACHIEVEMENT; BRACHYTHERAPY; CANCER CELL; CANCER CONTROL; CANCER THERAPY; CLINICAL TRIAL; EXTERNAL BEAM RADIOTHERAPY; FRACTIONATION; HUMAN; INTERMETHOD COMPARISON; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RADIOSENSITIVITY; REVIEW; ARTICLE; MALE; PROSTATE TUMOR; RADIATION DOSE FRACTIONATION;

DOSE FRACTIONATION; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 33748290307     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2179008     Document Type: Review

References (28)

1. J. F. Fowler, M. A. Ritter, R. J. Chappell, and D. J. Brenner, "What hypofractionated protocols should be tested for prostate cancer?" Int. J. Radiat. Oncol., Biol., Phys. 56, 1093-2003 (2003).
2. A. E. Nahum et al., "Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the α/β ratio," Int. J. Radiat. Oncol., Biol., Phys. 57, 391-401 (2003).
3. K. Haustermans and J. F. Fowler, "A comment on proliferation rates in human prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 48, 291 (2000).
4. D. J. Brenner and E. J. Hall, "Fractionation and protraction for radiotherapy of prostate carcinoma," Int. J. Radiat. Oncol., Biol., Phys. 43, 1095-1101 (1999).
5. J. F. Fowler, R. J. Chappell, and M. A. Ritter, "Is α/β for prostate tumors really low?" Int. J. Radiat. Oncol., Biol., Phys. 50, 1021-1031 (2001).
6. D. J. Brenner et al., "Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio) comparable to late-responding normal tissue," Int. J. Radiat. Oncol., Biol., Phys. 52, 6-13 (2002).
7. J. Z. Wang, M. Guerrero, and X. A. Li, "How low is the α/β ratio for prostate cancer?" Int. J. Radiat. Oncol., Biol., Phys. 55, 194-203 (2003).
8. C. D. Collins, R. W. Lloyd-Davies, and A. V Swan, "Radical external beam radiotherapy for localized carcinoma of the prostate using a hypofractionation technique," Clin. Oncol. 3, 127-132 (1991).
9. J. E. Livsey et al., "Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis," Int. J. Radiat. Oncol., Biol., Phys. 57, 1254-1259 (2003).
10. T. Djemil, C. A. Reddy, T. R. Willoughby, and P. Kupelian, "Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer," Int. J. Radiat. Oncol., Biol., Phys., Suppl. 57, S275-S276 (2003).
11. Y. Yoshioka et al., "High-dose-rate brachytherapy as monotherapy for localized prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicity," Int. J. Radiat. Oncol., Biol., Phys. 56, 213-220 (2003).
12. B. L. Madsen et al., "Intra-fractional stability of the prostate using a stereotactic radiotherapy technique," Int. J. Radiat. Oncol., Biol., Phys. 57, 1285-1291 (2003).
13. G. Gustafson et al., "High dose rate (HDR) monotherapy for early stage prostate cancer: toxicity results utilizing the common toxicity criteria," Int. J. Radiat. Oncol., Biol., Phys. 57, S230-S231 (2003).
14. H. Lukka et al., "A randomized trial comparing two fractionation schedules for patients with localized prostate cancer," Radiother. Oncol. 69, (Supplement 1), S7 (2003).
15. S. M. Bentzen and M. A. Ritter, "The α/β ratio for prostate cancer: what is it, really?" Radiother. Oncol. 76, 1-3 (2005).
16. R. Valdagni et al., "Standard or hyperfractionated conformal radiation therapy in prostate cancer: A prospective non-randomized trial comparing standard and hyperfractionated conformal radiation therapy," Radiother. Oncol. 75, 74-82 (2005).
17. D. J. Demanes et al., "High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California Endocurietherapy's 10-year results," Int. J. Radiat. Oncol., Biol., Phys. 61, 1306-1316 (2005).
18. J. F. Fowler et al., "Analysis of 5y clinical results of EBRT + brachytherapy shows that α/β is low," Int. J. Radiat. Oncol., Biol., Phys.
19. G. E. Hanks et al., "Dose response in prostate cancer with 8-12 years' follow up," Int. J. Radiat. Oncol., Biol., Phys. 54, 427-435 (2002).
20. R. G. Stock et al., "A dose-response study for I-125 prostate implants," Int. J. Radiat. Oncol., Biol., Phys. 41, 101-108 (1998).
21. C. R. King and J. F. Fowler, "A simple analytic derivation suggests that prostate cancer α/β ratio is low," Int. J. Radiat. Oncol., Biol., Phys. 51, 213-214 (2001).
22. 2 predicts for biochemical failure in prostate cancer patients." Urology 60, 634-639 (2002).
23. A. E. Nahum and J. D. Chapman, "Dose-escalation strategies for increasing prostate local control: how clinically proven hypoxia radically changes the picture," Radiother. Oncol. 68, S113 (2003).
24. G. M. Duchesne and L. J. Peters, "What is the α/β ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 44, 747-748 (1999).
25. A. A. Martinez et al., "Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionation regime," Int. J. Radiat. Oncol., Biol., Phys. 62, 1322-1331 (2005).
26. P. A. Kupelian et al., "Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 63(5), 1463-1468 (2005).
27. D. J. Carlson et al., "Comparison of in vitro and in vivo α/β ratios for prostate cancer," Phys. Med. Biol. 49, 4477-4491 (2004).
28. J. F. Fowler et al., "A challenge to traditional radiation oncology," Int. J. Radiat. Oncol., Biol., Phys. 60(4), 1241-1256 (2004).